123
Participants
Start Date
December 31, 2009
Primary Completion Date
July 31, 2012
Study Completion Date
July 31, 2012
Factor IX (rFIXFc)
rFIX
Research Site, Phoenix
Research Site, Sacramento
Research Site, Aurora
Research Site, Chicago
Research Site, Indianapolis
Research Site, East Lansing
Research Site, Philadelphia
Research Site, Pittsburgh
Research Site, Seattle
Research Site, Camperdown
Research Site, Adelaide
Research Site, Perth
Research Site, Brussels
Research Site, Leuven
Research Site, Campinas
Research Site, Calgary
Research Site, Toronto
Research Site, Montreal
Research Site, Vancouver
Research site, Beijing
Research Site, Guangzhou
Research Site, Shanghai
Research Site, Tianjin
Research Site, Lyon
Research Site, Marseille
Research Site, Berlin
Research Site, Bonn
Research Site, Pokfulam
Research Site, Shatin
Research Site, Ludhiana
Research Site, Vellore
Research Site, Bangalore
Research Site, Pune
Research Site, Florence
Research Site, Milan
Research Site, Kasihara-City
Research Site, Kawasaki
Research Site, Kitakyushu
Research Site, Nagoya
Ressearch Site, Suginami-ku
Research Site, Tokyo
Research Site, Lodz
Research Site, Warsaw
Research Site, Moscow
Research Site, Saint Petersburg
Research Site, Johannesburg
Research Site, Cape Town
Research Site, Malmo
Research Site, Stockholm
Research Site, Cambridge
Research Site, London
Lead Sponsor
Collaborators (1)
Swedish Orphan Biovitrum
INDUSTRY
Bioverativ Therapeutics Inc.
INDUSTRY